Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01371019 · ClinicalTrials.gov registry record
Proteomic Assessment of Preterm Birth
A clinical trial, sponsored by Sera Prognostics.
- Completed
- Registry status
- 5,500
- Enrollment target
NCT01371019: Completed study, sponsored by Sera Prognostics.
NCT01371019 is a clinical trial that has completed, run by Sera Prognostics. The registered enrollment target is 5,500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01371019 has completed, sponsored by Sera Prognostics.
- COMPLETED
- Registry status
- 5,500 participants
- Enrollment target
Study Summary
The purpose of this study is to to collect and store blood samples that will be utilized to develop a multimarker test to predict preterm delivery.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,500 participants |
| Start Date | 2011-04 |
| Est. Completion | 2015-04 |
What the finished NCT01371019 record still lists
NCT01371019 is an observational study that tracks outcomes without assigning an intervention. Its 5,500 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01371019 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01371019 about?
NCT01371019 is a clinical study titled "Proteomic Assessment of Preterm Birth". The purpose of this study is to to collect and store blood samples that will be utilized to develop a multimarker test to predict preterm delivery.
What is the current status of trial NCT01371019?
This trial is currently completed. The enrollment target is 5,500 participants. The study started on 2011-04. Estimated completion is 2015-04.
Who is sponsoring clinical trial NCT01371019?
This trial is sponsored by Sera Prognostics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05952557 · 5,500 participants · Phase 3
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
- NCT06084234 · 5,500 participants · Phase 4
National Liver Cancer Screening Trial
- NCT07146568 · 5,515 participants · NA
Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital
- NCT04295486 · 5,478 participants · Phase 2
Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia